Aware, Inc. (NASDAQ:AWRE – Get Free Report) saw a significant decline in short interest in June. As of June 15th, there was short interest totalling 31,000 shares, a decline of 18.2% from the May 31st total of 37,900 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average trading volume of 40,900 shares, the short-interest ratio is presently 0.8 days.
Aware Price Performance
NASDAQ AWRE traded down $0.01 during trading hours on Tuesday, reaching $1.92. 8,189 shares of the stock traded hands, compared to its average volume of 47,120. The stock has a 50 day simple moving average of $1.89 and a two-hundred day simple moving average of $1.79. Aware has a 1 year low of $1.05 and a 1 year high of $2.20. The company has a market cap of $40.47 million, a price-to-earnings ratio of -5.82 and a beta of 0.80.
Aware (NASDAQ:AWRE – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The software maker reported ($0.05) earnings per share for the quarter. The firm had revenue of $4.42 million for the quarter. Aware had a negative net margin of 36.65% and a negative return on equity of 13.16%.
Institutional Inflows and Outflows
About Aware
Aware, Inc, an authentication company, provides biometrics software products and solutions for government agencies and commercial entities in the United States, the United Kingdom, and internationally. The company offers biometric software solution, including Knomi, a mobile biometric framework which provides multiple biometric modality options; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification, as well as AFIX Face, AFIX Verifier, AFIX Identifier, AFIX Comparator, AFIX Engine, and AFIX NIST Transaction Engine.
See Also
- Five stocks we like better than Aware
- Trading Stocks: RSI and Why it’s Useful
- RXO Shares Surge Following New Acquisition Deal
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Aware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aware and related companies with MarketBeat.com's FREE daily email newsletter.